- Home
- ANIP vs MCRI Comparison
ANIP vs MCRI Comparison
Compare ANIP & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIP | MCRI |
|---|---|---|
| Founded | 2001 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 1999 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ANIP | MCRI |
|---|---|---|
| Price | $73.57 | $115.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $105.78 | ★ $126.50 |
| AVG Volume (30 Days) | ★ 378.2K | 136.3K |
| Earning Date | 11-06-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ 419.23 | 41.41 |
| EPS | ★ 2.32 | 1.52 |
| Revenue | $206,547,000.00 | ★ $395,377,000.00 |
| Revenue This Year | $24.85 | $4.74 |
| Revenue Next Year | $10.76 | $1.85 |
| P/E Ratio | ★ $31.75 | $75.82 |
| Revenue Growth | 2.47 | ★ 114.40 |
| 52 Week Low | $69.58 | $88.13 |
| 52 Week High | $96.99 | $135.93 |
Technical Indicators
Market Signals| Indicator | ANIP | MCRI |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 39.88 |
| Support Level | $72.96 | $113.32 |
| Resistance Level | $83.03 | $121.15 |
| Average True Range (ATR) | 2.07 | 2.17 |
| MACD | 0.04 | -0.14 |
| Stochastic Oscillator | 32.40 | 30.19 |
Price Performance
Historical ComparisonAbout ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.